| ²é¿´: 6659 | »Ø¸´: 6 | |||
ÑôÑòyyyгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÇëÎÊCmax/AUCÕâ¸ö²ÎÊýÓÐʲô×÷Óà ÒÑÓÐ1È˲ÎÓë
|
| Çë½Ì¸÷λ£ºCmax/AUCÕâ¸ö²ÎÊýÓÐʲô×÷Óã¿¿ÉÒÔÓÃÀ´ºâÁ¿Ò©ÎïÎüÊÕÂÊÂð£¿ÎªÊ²Ã´£¿Ð»Ð»¸÷λÁË |
» ²ÂÄãϲ»¶
ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ17È˻ظ´
ÃæÉϺÏ×÷µ¥Î»¸ÇÕÂ
ÒѾÓÐ5È˻ظ´
Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ
ÒѾÓÐ8È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ7È˻ظ´
ÉêÇëɾ³ý±¾Ìû
ÒѾÓÐ7È˻ظ´
»ù½ð²»ÖУ¬¹²Ãã
ÒѾÓÐ10È˻ظ´
¹ú×ÔÈ»ÃæÉϸ´ÅÌ~»¶ÓÌÖÂÛ
ÒѾÓÐ11È˻ظ´
»ù½ðδÖУ¬ÕâÖÖ´ð¸´ÊÇÄ£°åÂð£¿
ÒѾÓÐ6È˻ظ´
¿´°åÉÏÕâô¶àÖеģ¬ÓеãÏñ50ÈËȺÀï49¸öÈ˶¼ÊÇÆ×ÓµÄÄÇÖָоõ¡¡
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú£ºAUCºÍÉúÎïÀûÓöÈÖ®¼äÔõô»»Ëã°¡£¿Ò»¸öÒ©ÎïÔÚÌåÄÚµÄÉúÎïÀûÓöȴﵽ80%Ëã¸ßÂð£¿
ÒѾÓÐ3È˻ظ´
¾²ÂöµÎ×¢Óë¿Ú·þ¸øÒ©µÄÇø±ð
ÒѾÓÐ9È˻ظ´
Ò©Îï·ÇÏßÐÔÎüÊÕ
ÒѾÓÐ14È˻ظ´
ÇóÖúÖÎÁÆÒÖÓôµÄÐÀ°Ù´ï(ÑÎËá¶ÈÂåÎ÷Í¡³¦ÈܽºÄÒµÄ˵Ã÷Ê飬×îºÃÊÇPDF°æ±¾µÄ£¡
ÒѾÓÐ8È˻ظ´
¡¾ÌÖÂÛ¡¿Ò©Îﱩ¶
ÒѾÓÐ10È˻ظ´
¡¾·ÖÏí¡¿Çë½ÌÒ©Àíѧ·½ÃæµÄǰ±²
ÒѾÓÐ12È˻ظ´

chem_sq
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 84 (³õÖÐÉú)
- ½ð±Ò: 4096.5
- ºì»¨: 11
- Ìû×Ó: 2116
- ÔÚÏß: 345.5Сʱ
- ³æºÅ: 770390
- ×¢²á: 2009-05-14
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
karl2100: ½ð±Ò+1, лл£¡ 2013-05-03 23:27:39
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
karl2100: ½ð±Ò+1, лл£¡ 2013-05-03 23:27:39
|
Cmax:Ѫҩ´ï·åŨ¶È AUC£ºÑªÒºÅ¨¶ÈµÄÇúÏßÏÂÃæ»ý Á½¸öÊýÖµ»ù±¾¿ÉÒÔ·´Ó¦Ò©´ú¶¯Á¦Ñ§ÖеÄÎüÊÕÇé¿ö¡£Äã˵µÄÎüÊÕÂÊÊÇÖ¸ÉúÎïÀûÓöȰɣ¬Õ⻹Ҫ¿´Ò©ÎïµÄ´úлºÍÅÅйÇé¿ö |
2Â¥2013-05-03 11:08:19
ÑôÑòyyy
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 303.7
- ºì»¨: 1
- Ìû×Ó: 39
- ÔÚÏß: 14Сʱ
- ³æºÅ: 1688370
- ×¢²á: 2012-03-13
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ

3Â¥2013-05-03 16:28:08
ÐÇÐǵÄÑÛ¾¦
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- PhEPI: 1
- Ó¦Öú: 1634 (½²Ê¦)
- ½ð±Ò: 7796.8
- ºì»¨: 41
- Ìû×Ó: 2694
- ÔÚÏß: 824.5Сʱ
- ³æºÅ: 2261661
- ×¢²á: 2013-01-26
- רҵ: Ò©¼Áѧ
4Â¥2013-05-04 22:13:53
zhoupeng87
°æÖ÷ (ÎÄѧ̩¶·)
- Ó¦Öú: 6148 (¸±½ÌÊÚ)
- ¹ó±ö: 8.516
- ½ð±Ò: 47410.3
- É¢½ð: 58001
- ºì»¨: 566
- ɳ·¢: 2391
- Ìû×Ó: 64964
- ÔÚÏß: 9636.5Сʱ
- ³æºÅ: 962700
- ×¢²á: 2010-03-06
- ÐÔ±ð: GG
- רҵ: ÎÞ»ú²ÄÁÏ»¯Ñ§
- ¹ÜϽ: ¾«Ï¸»¯¹¤
5Â¥2013-05-06 10:06:25
zhangxuan200
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- PhEPI: 2
- Ó¦Öú: 101 (¸ßÖÐÉú)
- ½ð±Ò: 11138
- ºì»¨: 6
- Ìû×Ó: 311
- ÔÚÏß: 559.7Сʱ
- ³æºÅ: 95949
- ×¢²á: 2005-10-07
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
Endrenyi and co-workers (1991, 1993) were the first to show that Cmax/AUC is a better characteristic of the absorption rate than Cmax itself. They showed that the ratio Cmax/AUC is independent of both within-subject variations and possible differences in the extent of absorption and ¨C in the case of a one-compartment body model with firstorder absorption ¨C reflects only the contrast between the absorption and disposition rate constants, ka/kel. Lacey et al. (1994) considered simulated and real experiments and came up with the conclusion that Cmax/AUC is a more powerful metric than Cmax in establishing bioequivalence when formulations are truly bioequivalent, and that Cmax/AUC is more sensitive than Cmax at detecting differences in rate of absorption when they exist. Schall and co-workers (1994) showed that under fairly general conditions tmax and Cmax/AUC are equivalent characteristics of the absorption rate. Cmax/AUC can be observed with higher precision, and is easier to handle statistically than tmax. On the basis of data from 20 bioequivalence studies they came up with the rather subtle recommendation that for drugs with short (<5 hours) elimination half-lives or fastest disposition half-lives in the case of higher compartmental models, Cmax/AUC is the best rate characteristic, but that for drugs with long elimination or fastest disposition half-lives, tmax can be superior to Cmax/AUC. |
6Â¥2013-05-14 08:48:19
7Â¥2014-05-25 18:18:23









»Ø¸´´ËÂ¥

10